Inventurus Knowledge Solutions

Inventurus Knowledge Solutions Limited - IPO

MAINBOARD

Inventurus Knowledge Solutions Stock Price

1668.10 A2ZIPO
14.20 (0.86%)
16 May, 2025 12:14:54 PM | All Prices in ₹
Previous Close
1653.90
Open
1702.00
High
1739.90
Low
1637.60
Exchange
NSE
52 week High (26 Dec 2024)
2189.00
52 week Low (07 Apr 2025)
1236.80
Upper Price Band
1984.60
Lower Price Band
1323.20
Price Band
20.00%
1669.15 A2ZIPO
18.60 (1.13%)
16 May, 2025 04:01:00 PM | All Prices in ₹
Previous Close
1650.55
Open
1709.85
High
1738.00
Low
1637.70
Exchange
BSE
52 week High
2190.00
52 week Low
1226.15
Upper Price Band
1980.65
Lower Price Band
1320.45
Price Band
20.00%

Inventurus Knowledge Solutions IPO Details

Open Date
12 Dec 2024
Close Date
16 Dec 2024
Listing Date
19 Dec 2024
Issue Price
₹1265 - ₹1329
Face Value
₹1 per share
Lot Size
11
GMP
₹421 (31.7%)
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
171573159
Share holding post issue
171573159
Total Issue Size
1,87,95,510 shares (aggregating up to ₹2,497.92 Cr)
Fresh Issue
-
Offer for Sale
1,87,95,510 shares (aggregating up to ₹2,497.92 Cr)

Inventurus Knowledge Solutions IPO Subscription

Inventurus Knowledge Solutions IPO Application Wise Breakup (Approx)

Inventurus Knowledge Solutions IPO Dates

  • 12 Dec 2024
    Opening dateOPD
  • 16 Dec 2024
    Closing dateCOD
  • 17 Dec 2024
    Basis of AllotmentBOA
  • 18 Dec 2024
    Initiation of RefundsIOR
  • 18 Dec 2024
    Credit of SharesCOS
  • 19 Dec 2024
    Listing dateLID

Inventurus Knowledge Solutions IPO Lot Size

ApplicationLotsSharesAmount
Retain Minimum111₹14,619
Retain Maximum13143₹190,047
SHNI Minimum14154₹204,666
SHNI Maximum68748₹994,092
BHNI Minimum69759₹1,008,711

Inventurus Knowledge Solutions IPO Reservation

Promoter Holding

Pre Issue:69.73%
Post Issue:65.81%
Promoter Names:
Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, Nishtha Jhunjhunwala Discretionary Trust

Inventurus Knowledge Solutions IPO Valuations

ROE:32%
Debt/Equity:-0.06
RoNW:32%
PAT Margin (%):20.38
EPS Pre IPO:21.59
EPS Post IPO:21.59

Inventurus Knowledge Solutions Limited Financial Information

Inventurus Knowledge Solutions Limited's revenue increased by 75% and profit after tax (PAT) rose by 21% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets3,027.52988.31787.52
Revenue1,857.941,060.16784.47
Profit After Tax370.49305.23232.97
Net Worth1,157.86828.64647.07
Reserves and Surplus1,140.94811.8630.26
Total Borrowing1,193.42
Amount in ₹ Crore

About Inventurus Knowledge Solutions IPO

Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more.

The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers.

Inventurus Knowledge Solutions Limited offer a platform that enables healthcare enterprises in outpatient and inpatient care.

  • Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services.
  • Inpatient care refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.

As of March 31, 2024, IKS serves over 800 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.

The company has a team of over 13,241 employees, including 3,111 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia.

Strength Of Inventurus Knowledge Solutions IPO

1. Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.

2. Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.

3. Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.

4. Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.

5. Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

6. Healthy financial performance with growth and improving margins.

7. Experienced and entrepreneurial driven leadership team.

Risk Of Inventurus Knowledge Solutions IPO

1. There have been certain FEMA related deficiencies in compliances in the past by our Company and some of our existing and erstwhile shareholders, with respect to issuance of securities of our Company, delays in relation to reporting requirements and transfer of securities of our Company. We have filed compounding applications with the RBI in respect of such contraventions, which are currently pending. Consequently, we may be subject to regulatory actions and penalties/ compounding fees, as applicable.

2. We have outstanding litigation against us, an adverse outcome of which may adversely affect our business, reputation and results of operations.

3. If we fail to successfully develop and introduce new solutions based on artificial intelligence and machine learning technologies and features to existing solutions such as AI-powered speech-to-text solutions, our revenues, operating results and reputation could suffer.

4. The healthcare industry is regulated and if we fail to comply with applicable healthcare laws and government regulations, we could incur financial penalties, be required to make significant operational changes or experience adverse publicity, which could harm our business.

5. Various challenges currently faced by the healthcare industry in the United States including the provision of quality healthcare in a competitive environment and managing costs at the same time and consolidation of healthcare organizations in the United States may adversely affect our business, results of operations and financial condition.

6. Our revenues are dependent on our ability to maintain and expand existing client relationships and our ability to attract new clients. As of September 30, 2024 and 2023 and as of March 31, 2024, 2023 and 2022, we had 778, 42, 853, 49 and 45 clients. A loss of one or more clients could have an adverse impact on our results of operations, financial condition and cash flows.

7. We have recently acquired Aquity Holdings to further our strategic objectives. Our inability to successfully integrate the operations of Aquity or the operations of any entities that we may acquire could adversely impact our business, financial condition, results of operations, cash flows and prospects.

8. Our Company will not receive any proceeds from the Offer. Some of our Shareholders are selling shares in the Offer and will receive proceeds as part of the Offer for Sale.

9. Delays in receiving payment of outstanding dues from clients may affect our financial condition and results of operations.

10. Our revenues are primarily dependent on revenue generated from healthcare organizations based in the United States, and as a result, we are subject to the risks of sector and geographic concentration.

Objectives Inventurus Knowledge Solutions IPO

The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

Company Contact Details

Inventurus Knowledge Solutions Limited
Building No. 5 & 6, Unit No. 801,
8th Floor, Mindspace SEZ, Thane Belapur Road,
Airoli, Navi Mumbai, Thane, 400708
Phone: +91 22 3964 3205
Email: company.secretary@ikshealth.com
Website: https://ikshealth.com/

Registrar Contact Details

Name: Link Intime India Private Ltd
Phone: +91-22-49186200

Lead Mangers

  1. ICICI Securities Limited

  2. Jefferies India Private Limited

  3. J.P. Morgan India Private Limited

  4. Nomura Financial Advisory And Securities (India) Pvt Ltd

  5. Jm Financial Limited

Comments